OraSure Technologies | OSUR - 现金及等价物



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 282.3M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


现金及等价物 更改 日
Agilent USD 1.81B 49M 2026-03
AngioDynamics USD 41.64M 14.26M 2025-09
Becton, Dickinson and Co. USD 708M 105M 2026-06
Bio Techne USD 264.71M 54.89M 2026-06
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Cerus USD 19.96M 4.29M 2025-12
Charles River Laboratories USD 192.02M 195K 2026-06
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
Dexcom USD 1.1B 13.2M 2026-06
Illumina USD 1.09B 329M 2026-03
Integra LifeSciences USD 214.42M 22.39M 2026-06
Intuitive Surgical USD 8.63B 646.3M 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Mesa Laboratories USD 28.98M 8.55M 2025-12
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
OraSure Technologies USD 160.58M 16.38M 2026-06
Quidel USD 123.4M 17M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
STAAR Surgical USD 148.58M 16.72M 2026-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Trinity Biotech USD 5.14M 3.8M 2025-12
Waters USD 539M 77M 2026-06